⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
HIMS
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
HIMS
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Stockholders to Reach Out
accessnewswire.com
HIMS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Stockholders to Connect
accessnewswire.com
HIMS
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
HIMS
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
HIMS
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
HIMS
Bronstein, Gewirtz & Grossman, LLC Encourages Hims & Hers Health, Inc. (HIMS) Investors to Inquire about Securities Investigation
accessnewswire.com
HIMS
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
globenewswire.com
NVO
HIMS